Johnson & Johnson
Johnson & Johnson is the world’s largest health care company. It is also the highest paid drug company in the world. J&J remains at the top of the Big Pharma list of powerful corporations. It is well known for consumer products like Band-Aids, Johnson’s Baby Powder and Tylenol. Its drugs, devices and products have led to scandals and lawsuits.
Johnson & Johnson has built a health care empire. It includes prescription and over-the-counter drugs, orthopedic implants, surgical products and household products.
The most popular brands include Band-Aids, Tylenol and Johnson’s Baby Powder. Still, more than 90 percent of J&J’s revenue comes from prescription drugs and medical devices.
A Huffington Post investigation called J&J “America’s most admired lawbreaker.”
J&J has been at the center of scandals and government investigations. It has issued recalls of some of its drugs and devices.
Consumers harmed by J&J products are suing the company. They question the company’s motives and say it puts profits over people.
In 2019, it recalled tens of thousands of bottles of its iconic Johnson’s Baby Powder after the FDA found small amounts of asbestos in a sample.
Then in May 2020, the company said it would stop selling talcum-based baby powder in Canada and the United States after state juries ordered the company to pay billions of dollars to people who claimed the product gave them cancer.
The company said it stopped selling the product because of low sales. It still faces more than 20,000 federal talcum powder lawsuits in multidistrict litigation and many more in state courts as of September 2020.
In October 2020, Johnson & Johnson agreed to settle more than 1,000 talcum powder lawsuits for $100 million.
Lawyers in the federal lawsuits expect to prepare for bellwether trials soon but none have been scheduled as of September 2020.
About Johnson & Johnson
Johnson & Johnson has over 125,000 employees spread across 60 countries. Its main headquarters is in New Brunswick, New Jersey.
J&J brought in more than $76 billion in 2017. It ranked No. 1 in annual revenue among its competitors.
Alex Gorsky is its CEO. He is the seventh CEO to head J&J.
Johnson & Johnson History
Robert, James and Edward Johnson founded Johnson & Johnson in 1886 in New Brunswick, New Jersey. The company focused on bandages, sterile sutures and wound care.
The company also sold women’s health products. These included sanitary protection products. It also sold maternity kits with first-aid products to make childbirth safer.
J&J created the first commercial dressings applied by consumers. We know this product made in 1921 as Band-Aids.
Johnson & Johnson Subsidiaries
Johnson & Johnson is a parent company for over 250 subsidiaries. Together, the companies make up “the Johnson & Johnson family of companies.”
- Biosense Webster
- J&J Vision Care (Acuvue)
- Animas Corporation (OneTouch)
- Advanced Sterilization Products (ASP)
- J&J Holdings
Popular Johnson & Johnson Products
Johnson & Johnson products fall into three categories. These include consumer health care products, medical devices and pharmaceutical drugs.
- sodium-glucose cotransporter 2 (SGLT2) inhibitor to treat Type 2 diabetes
- pain reliever
- fluoroquinolone antibiotic
- antipsychotic drug
- medication used to prevent seizures and migraines
- blood thinner
- ADHD drug
- Power Morcellators
- device used to remove fibroids
- Transvaginal Mesh
- net-like implant for treating pelvic organ prolapse and stress urinary incontinence
- Hip Replacement
- artificial joint
- Knee Replacement
- artificial implant
- Johnson's Baby Powder
- personal care product that contains talc
Notable Johnson & Johnson Recalls
Johnson & Johnson recalled some of its most popular products after patients reported injuries. The FDA and other government agencies investigated.
1982 - McNeil
Product Recalled - Tylenol (acetaminophen) capsules
Reason for Recall - Medicine laced with potassium cyanide (poison) resulting in several patient deaths
2009 to 2011 - McNeil
Product Recalled - Several OTC medicines including Tylenol, Motrin, Benadryl, St. Joseph aspirin, Sudafed, Pepcid, Mylanta, Rolaids, Zyrtec, Zyrtec Eye Drops (tens of millions of bottles)
Reason for Recall - Unpleasant smells causing nausea; tiny metal shards in liquid medicines; wrong ingredient levels
2010 - DePuy [Pinnacle Systems]
Product Recalled - ASR Hip Resurfacing System and ASR XL Acetabular System (metal-on-metal hip implants)
Reason for Recall - Metal poisoning (metallosis); loosening of the implant or joint dislocation; additional surgeries
2012 - Ethicon
Product Recalled - Gynecare Prolift Kit, Gynecare Prolift+M Kit, Gynecare TVT Secure and Gynecare Prosima Pelvic Floor Repair System Kit (transvaginal mesh implants)
Reason for Recall - Perforation of organs; vaginal bleeding and scarring; mesh erosion; severe pain
2013 - McNeil
Product Recalled - Motrin (ibuprofen) for infants (200,000 liquid bottles)
Reason for Recall - May contain tiny particles of plastic
2013 - Janssen
Product Recalled - Risperdal Consta (injectable antipsychotic drug) (one lot)
Reason for Recall - Routine testing showed evidence of mold
- 2014 - Ethicon
2016 - Ethicon
Product Recalled - Physiomesh flexible composite hernia mesh
Reason for Recall - Studies showed higher revision rates after implant
2017 - SterilMed
Product Recalled - Agilis Steerable Introducer Sheath (hemostatic heart valve)
Reason for Recall - Device failure due to an improper seal of the sheath hub, which can allow blood leakage, device detachment during the procedure or development of an air embolism
2019 – Johnson & Johnson
Product Recalled – 33,000 bottles of Johnson’s Baby Powder
Reason for Recall – The FDA found a small amount of asbestos — a known carcinogen — in a sample
Johnson & Johnson Lawsuits
J&J has faced hundreds of thousands of lawsuits over claims its products are defective.
Lawsuits point to internal documents showing J&J and its subsidiaries knew about problems with their products but sold them anyway.
In addition to individual product liability lawsuits, individual states who say Johnson & Johnson helped fuel the opioid crisis are suing the company for millions of dollars.
- DePuy ASR XL Acetabular System and DePuy ASR Hip Resurfacing System
Number of Lawsuits - 2,897
Injuries - dislocation, loosening, metallosis (metal poisoning), revision surgeries
- Pinnacle Acetabular Cup
Number of Lawsuits - 7,992
Injuries - dislocation, loosening, metallosis (metal poisoning), revision surgeries
- Pelvic (Transvaginal) Mesh
Number of Lawsuits - 284
Injuries - erosion, infection, pain, urinary problems, recurring prolapse, recurring incontinence
Number of Lawsuits - 12,597
Injuries - severe, sometimes deadly bleeding events, blood clots, wound leaks, infection
The company is facing smaller, emerging litigations for the interstitial cystitis (IC) drug Elmiron and DePuy’s Attune knee implants.
Elmiron litigation is in the beginning stages with a handful of cases filed in state courts, but lawyers expect hundreds more. People who filed lawsuits say Johnson & Johnson’s Janssen Pharmaceuticals unit failed to warn them that the drug could cause vision problems, particularly a condition called pigmentary maculopathy.
DePuy’s Attune knee implant litigation is ongoing, and people who filed lawsuits say the implant loosened and failed leading to pain and revision surgery.
DePuy hip litigation is ongoing, and juries have awarded more than a billion dollars to plaintiffs who say they were injured by faulty Pinnacle hip implants. In February 2019, Bloomberg reported the company may be willing to pay $400 million to settle 3,300 of the claims but was not offering a global settlement.
Major Johnson & Johnson Verdicts and Settlements
J&J was involved in seven of 2017’s top ten health-care-related verdicts.
The company was also involved in the third-largest pharmaceutical settlement with the U.S. Department of Justice. In 2013, J&J paid the Justice Department more than $2.2 billion. The settlement resolved civil and criminal allegations involving Risperdal, Invega and Natrecor.
A jury in Missouri ordered J&J to pay $72 million in a Johnson’s Baby Powder case. An appeals court tossed the verdict in 2017.
A jury in Texas awarded five patients $500 million in a Pinnacle hip implant case. State law required the award be cut to $150 million.
A jury awarded $1 billion to six patients in a Pinnacle hip implant case. A judge slashed the award to $543 million.
A jury in Philadelphia ordered J&J to pay $20 million in a transvaginal mesh lawsuit.
A jury in Missouri awarded $110.5 million to a woman who developed ovarian cancer after using Johnson’s Baby Powder and Shower to Shower talcum powder. J&J planned to appeal the verdict.
J&J paid $33 million to most U.S. states and the District of Columbia. The states charged J&J with misrepresenting the manufacturing practices behind certain drugs. This included its Motrin products. These products were later recalled.
A California jury ordered J&J to pay $417 million in a Johnson’s Baby Powder and talcum powder case. A trial judge overturned the verdict in October 2017 and ordered a new trial.
A federal jury in Dallas ordered J&J to pay six patients $247 million in a Pinnacle hip implant case. J&J said it planned to appeal the verdict.
A federal jury in Philadelphia ordered J&J to pay $27.8 million in a Xarelto bleeding lawsuit. A judge overturned the verdict in 2018.
A New Jersey federal jury issued a verdict of $15 million against J&J in a Prolift pelvic mesh case.
An Indiana jury awarded a woman $35 million in a Prolift pelvic mesh case. J&J planned to appeal the verdict.
Please seek the advice of a medical professional before making health care decisions.
- Abbott Laboratories
- AbbVie Inc
- Boehringer Ingelheim
- Boston Scientific
- Bristol-Myers Squibb
- C.R. Bard
- Cook Medical
- Daiichi Sankyo
- Eli Lilly & Co.
- Endo International and American Medical Systems
- GlaxoSmithKline (GSK)
- Johnson & Johnson
- Merck & Co.
- Stryker Corporation
- Takeda Pharmaceuticals